Beruflich Dokumente
Kultur Dokumente
Previous name
Cause
Mode of
transmission
Hepatitis A
Hepatitis B
Hepatitis C
Infectious Hepatitis
Serum Hepatitis
Non-A, Non-B
Hepatitis
Hepatitis D
Hepatitis E
Hepatitis A Virus
(HAV)
Hepatitis B Virus
(HBV)
Hepatitis C Virus
(HCV)
Hepatitis D Virus
(HDV)
Hepatitis E Virus
(HEV)
Fecal-oral route;
poor sanitation.
Person-to-person
cotact. Water-borne;
food-borne
Same as HBV
Fecal-oral route
Transfusion of blood
and blood products;
Oral-anal contact
during sex
Abrupt
Slow
Slow
Abrupt
Abrupt
Incubation
(weeks)
2-6
6-24
5-12
3-13
3-6
S/sx
Similar to HBV
Chronic Hepatitis
Cirrhosis
Liver cancer
Chronic Hepatitis
Cirrhosis
Liver cancer
Chronic Hepatitis
Cirrhosis
Fulminant Hepatitis
Similar to HAV
except very severe in
pregnant women
Positive HBsAg
(HBV surface
antigen); anti-HBV
antibodies present
Anti-HCV antibodies
present
Positive HDVAg
(delta antigen); antiHDV antibodies later
Anti-HEV antibodies
present
Onset
Pre-icteric phase:
Headache, malaise.
Fatigue, anorexia,
fever, body aches
Possibile
complications
Laboratory
Findings
Icteric phase:
Dark urine, jaundice
of sclera and skin,
tender liver
Rare
Anti-HAV antibodies
present
May develop
arthralgias, rash
Hepatitis A
Formerly
called
Infectious
Hepatitis
It is caused by an RNA virus of
the Enterovirus family
It is transmitted through the
fecal-oral
route,
by
the
ingestion
of
food,
water,
shellfish, and direct contact with
the person infected by the
Assessment
- IgM level
- Liver function test
- Bile examination in stool and urine
Management
Diagnostic Findings
- Elavated serum transferase levels
*Alanine Aminotransferase (ALT) and
Aspartate Aminotransferase (AST)
-Anti-HAV
Hepatitis B
-Alpha-interferon
-Lamivudine (Epivir)
-Adefovir (Hepsera)
-Oral nucleoside
-Adequate nutrition
-Bed rest
Nursing management
conditions,
multiple
sexual
partners, history of STD, receipt
of blood or blood products
Assessment
Incubation period, 2 to 3
months.
Prodromal symptoms (insidious
onset): fatigue, anorexia,
transient fever, abdominal
discomfort, nausea, vomiting,
headache.
May also have myalgias,
photophobia, arthritis,
angioedema, urticaria,
maculopapular rash, vasculitis.
Icteric phase occurs 1 week to 2
months after onset of
symptoms.
Diagnostic Findings
Radio-immunoassayhemaglutinin test
Blood count
HbsAg
Management
-Goal of tx is to minimize infectivity
and liver inflammation and decrease
symptoms.
-Nurse identifies psychosocial issues
and concerns
-Planning is required to minimize
social isolation
-Planning that includes the family
helps to reduce their fears and
anxieties about the spread of the
diseases
Hepatitis C
Formerly called non-A, non-B
hepatitis, usually spreads through
blood or blood product transfusion,
usually from asymptomatic blood
donors; HCV is the most common form
of postransfusion hepatitis.
Risk factors for Hepatitis C: Recipient
of blood products or organ transplant,
health care and public safety workers
after needle stick injuries or mucosal
exposure to blood, Past/ current illicit
IV/ injection drug use, past tx with
chronic hemodialysis, multiple sexual
partners, hx of STD, unprotected sex
and it may also be transmitted
through unsterile piercing or tattooing
tools or dyes.
HCV is the most common reason for
liver transplantation.
Approximately 50% of HCV develop
to chronic liver disease and at least
20% progress to cirrhosis
Assessment
-clinical findings are similar to HBV but
symptoms are usually mild
Diagnostic findings
1. Elevated serum transferase levels
ALT, AST
2. Hepatitis C antibody may not be
detected for 3 to 6 months after onset
of HCV illness.
Management
-No benefit from rest, diet or vitamin
supplements
-Combination therapy of interferon
(Intron-A) and ribavirin (Rebetol) is
effective for treating relapses. *WOF:
Hemolytic Anemia
-Alcohol and hepatotoxic drugs should
be avoided.
-Close monitoring is imperative.
Nursing management
1. Encourage verbalization of feelings
of anxiety of family members as well
as the patient when the disease is
diagnosed.
2.
Always
observe
standard
precautions in handling blood and
body fluids.
3. Always instruct patient and care
givers to properly dispose used
needles in a puncture resistant
container.
4. Emphasize proper nutrition, a highcalorie, low-fat diet is small frequent
feedings should be given.
5. Always monitor the vital signs as
well as markers if the disease
progresses.
Hepatitis D
Assessment
Diagnostic findings
1.
Elevated
serum
transferase
levels ALT, AST
2.
Anti-delta antibodies in the
presence
of
HBsAg
or the
detection of IgM in acute disease
and IgG in chronic disease.
Management
1.
Targeting the causative agent of
Hepatitis B may also kill the
causative agent of Hepatitis D.
2.
Antiviral therapy with interferon
alfa can be considered in patients
with chronic hepatitis D virus
Hepatitis E
The Hepatitis E virus is
described
to
be
a
nonenveloped, single-stranded RNA
virus. The natural reservoir of
this virus is primarily humans
but primates could also carry
such virus.
Like Hepatitis, it is transmitted
through
FecalOral
route
Fever
Diagnostic Findings
Management
Chronic Hepatitis
Is chronic infection of the liver
The primary cause of liver
damage leading to cirrhosis,
liver
cancer
and
liver
transplantation
HBV, HCV, HDV
Manifestations includes malaise,
fatigue, and heaptomegaly and
liver
enzymes
particularly,
serum amniotransferase level
are typically elevated
In chronic active hepatitis,
inflammation extends to involve
extends
to
involve
entire
hepatic lobule; it usually leads
to cirrhosis
Fulminant hepatitis
Rapidly progressive disease,
with liver failure developing
within 2 to 3 weeks
Although uncommon, it is
usually related to HBV with
concurrent HDV infection
Non-viral hepatitis
Toxic hepatitis
Toxic
hepatitis
is
an
inflammation of your liver in
reaction
to
certain
substances to which you're
exposed. Toxic hepatitis can
be
caused
by
alcohol,
chemicals, botanical agents,
drugs
or
nutritional
supplements.
S/sx
includes:
anorexia,
nausea
and
vomiting,
jaundice and hepatomegaly,
haemorrhages may appear
Recovery from acute toxic
hepatitis is rapid if the
hepatotoxin
if
identified
early and removed or if
exposure to the agent has
been limited.
Therapy is directed toward
restoring and maintaining
Drug-induced hepatitis
m/c cause of acute liver
failure
manifestation
of
senwsitivity
to
a
medication may occur on
the first day of its useor
not until several months
later, depending on the
medication
S/sx: onset is abrupt, with
chills,
fever,
rash,
pruritus,
arthralgia,
anorexia, and nausea.
Later, there may be
jaundice, dark urine and
enlarged and tender liver
Risk:
use
of
acetaminophen
(m/c
cause of ALF); anesthetic
agents, medications used
to treat rheumatic and
musculoskeletal disease,
antidepressants,
psychotropic meds, anti
convulsants
and
antituberculosis agents
Liver transplantation is
an
option
for
drug
induced hepatitis